Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 7788 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 779
  1. Net price*
    Year
  2. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015

    GlobalData
    151 pages
    GlobalData's clinical trial report, “Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015" provides data on the Axial Spondyloarthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Axial Spondyloarthritis. It includes an overview of the trial numbers and their
    Englisch | Zukunftsanalyse | SKU: 987672058
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Acute Respiratory Distress Syndrome – Pipeline Review, H1 2013

    Global Markets Direct
    71 pages
    Introduction Global Markets Direct’s, 'Acute Respiratory Distress Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage
    Englisch | Report | SKU: 324469
  4. $1,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    NeurAxon, Inc. – Product Pipeline Review – 2012

    Global Markets Direct
    32 pages
    Introduction Global Market Direct’s pharmaceuticals report, “NeurAxon, Inc. - Product Pipeline Review - 2012” provides data on the NeurAxon, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This
    Englisch | Report | SKU: 318163
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Anabasis Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    Anabasis Srl (Anabasis) is a biopharmaceutical company. The company develops therapies in the area of ophthalmology. It concentrates on nerve growth factor which required for the treatment of anterior and anterior part of the eye part of the eye. Anabasis provides services on the diseases such as neurotrophic keratitis, dry eye and glauco
    Englisch | Zukunftsanalyse | SKU: 331746
  6. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Dermira Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    27 pages
    Global Market Direct’s pharmaceuticals report, “Dermira Inc. - Product Pipeline Review - 2013” provides data on the Dermira Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built
    Englisch | Zukunftsanalyse | SKU: 386551
  7. $9,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022

    GlobalData
    542 pages
    After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Zukunftsanalyse | SKU: 401812
  8. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Idiopathic Pulmonary Fibrosis – Pipeline Review, H1 2013

    Global Markets Direct
    145 pages
    Introduction Global Markets Direct’s, 'Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with latest updates, and special features on late-stage and discont
    Englisch | Report | SKU: 318803
  9. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Sinusitis - Pipeline Review, H2 2014

    Global Markets Direct
    50 pages
    Global Markets Direct’s, ‘Sinusitis - Pipeline Review, H2 2014’, provides an overview of the Sinusitis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Sinusitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action
    Englisch | Zukunftsanalyse | SKU: 987671702
  10. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    AIDS-Related Complex Global Clinical Trials Review, H2, 2014

    GlobalData
    73 pages
    GlobalData's clinical trial report, “AIDS-Related Complex Global Clinical Trials Review, H2, 2014" provides data on the AIDS-Related Complex clinical trial scenario. This report provides elemental information and data relating to the clinical trials on AIDS-Related Complex. It includes an overview of the trial numbers and their recruitm
    Englisch | Zukunftsanalyse | SKU: 987672060
  11. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Central Nervous System (CNS) Tumor - Pipeline Review, H1 2013

    Global Markets Direct
    482 pages
    Global Markets Direct’s, 'Central Nervous System (CNS) Tumor - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Central Nervous System (CNS) Tumor, complete with latest updates, and special features on late-stage and discontinu
    Englisch | Zukunftsanalyse | SKU: 344498

Items 1 to 10 of 7788 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 779